These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-001805-90 Efficacy and security of glutamine dipeptide (Dipeptiven®) - Supplemented parenteral nutrition in critic patients. Double blind, randomized, multicenter study. 2007-05-25 due-trials
Reported results 2004-002108-14 Multizentrische Studie mit einer Niedrig-Natrium Peritonealdialyse-Lösung bei hypertensiven od. antihypertensiv behandelten CAPD Patienten auf balance Lösung 2006-05-15 due-trials
Completed, but no date, and reported results 2004-002724-17 Efficacy of Neodolpasse™ in the treatment of postoperative pain: Morphine sparing effect during the first 24 hours postoperatively after unilateral total hip arthroplasty. bad-data
Reported results 2005-002425-31 A double-blind, randomised study comparing the safety and tolerance of SMOFlipid 20% and Intralipid 20% in long-term treatment with parenteral nutrition 2008-10-24 due-trials
Reported results 2006-002589-20 Evaluación del acetato de calcio / carbonato de magnesio (OsvaRen®) en comparación con el sevelamer (Renagel®) en pacientes sometidos a hemodiálisis 2009-03-25 due-trials
Reported results 2006-004350-25 Crystalloids or colloids in patients with severe sepsis: effects on hemodynamics and tolerability of enteral nutrition 2010-05-27 due-trials
Reported results 2007-005365-35 Multicenter, parallel, controlled, randimized, single-blind clinical evaluation of new low sodium peritoneal dialysis solution on patients with hypertension treated with continuous ambulatory or autom... 2014-10-28 due-trials
Reported results 2007-006065-32 Evaluation of the efficacy of 6% hydroxyethyl starch (HES, 130/0.4) in normal saline compared to Ringer’s lactate solution for the prevention of hypotension during spinal anaesthesia for caesarean sec... 2009-12-17 due-trials
Reported results 2008-000429-20 A randomised, double-blind study evaluating the safety, tolerability, and amino acid plasma levels of Neoven compared to Vaminolact in infants after surgical interventions. 2009-12-18 due-trials
Reported results 2008-006749-18 Efficacy and safety of 6 % hydroxyethyl starch 130/0.4 (Voluven®) vs. 5% HSA in volume replacement therapy during elective open-heart surgery in paediatric patients 2010-08-05 due-trials
Reported results 2009-009427-11 Efecto de la solución de diálisis peritoneal balance sobre la membrana peritoneal de pacientes tratados con diálisis peritoneal automatizada (DPA) (The effect of balance peritoneal dialysis solution o... 2012-12-27 due-trials
Reported results Terminated 2009-012602-39 A randomised, double-blind study evaluating the safety, tolerability, protein accretion, amino acid plasma levels and long-term outcome of Neoven compared to Vaminolact(R) in premature very low birth ... 2011-03-15 due-trials
Reported results 2009-012603-26 A randomised, double-blind study evaluating the safety, tolerability and clinical outcome of Neoven compared to Vaminolact in premature ELBW infants 2011-03-18 due-trials
Reported results Terminated 2009-012604-92 A randomised, double-blind study of the safety and efficacy of Neoven compared to Vaminolact in infants and children requiring long-term parenteral nutrition 2011-03-18 due-trials
Reported results 2011-005734-18 Prospective randomised controlled open-label explorative multi-centre pilot trial of Volulyte®-supplemented versus Albumin-supplemented fluid resuscitation for major burns 2013-09-13 due-trials
Reported results 2012-004178-24 Study to investigate the therapeutic equivalence of OsvaRen® tablets and OsvaRen® granules 2015-04-30 due-trials
Reported results 2012-005701-43 Therapeutic Equivalence Study of Propofol Using Target-Controlled Infusion of Propofol 2% (20 mg/mL) MCT Fresenius Compared with Diprivan® 20 mg/mL (AstraZeneca) in Patients Undergoing Elective Surger... 2014-02-13 due-trials
Listed as ongoing, but also has a completion date 2016-002162-30 Prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) solution versus an electrolyte solution in patients unde... 2022-07-06 bad-data
Listed as ongoing, but also has a completion date 2016-002176-27 Pragmatic, prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of a 6% Hydroxyethyl starch (HES) solution versus an electrolyte solution in ... 2022-06-25 bad-data
Not reported Terminated 2017-001559-30 Efficacy of long-term parenteral nutrition with SmofKabiven® E concomitant to chemo- and/or immunotherapy: A prospective, randomised, controlled, open, multicentre, two-stage, adaptive clinical trial ... 2019-04-05 due-trials
Reported results Terminated 2017-001972-46 Reaching Protein Target with SmofKabiven extra Nitrogen Versus Olimel N9E: A Prospective, Randomised, Active-controlled, Patient-blinded, Multicentre Clinical Trial During the Early Phase of Acute Cri... 2020-09-07 due-trials
Reported results 2017-003555-35 A Multicentre, Randomised, Open-label, Parallel-Group Pilot Study to Evaluate the Efficacy of Patiromer in Optimising Mineralocorticoid Receptor Antagonist Therapy in Heart Failure Subjects with Hyper... 2019-10-31 due-trials
Reported results 2018-002359-14 Blood Glucose Response After Oral Intake of Lactulose (Laevolac®) in Mildly Constipated Patients with Diabetes Mellitus Type 2 2019-03-05 due-trials
Completed, report not yet due 2019-004369-42 A Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Two-Arm Study to Evaluate the Efficacy, Safety and Immunogenicity of MSB11456 Compared to European Union approved RoActemra® in Patients with... 2022-06-06 not-yet-due
Ongoing 2020-004422-31 A Double-blind, Randomized, Multicenter, Multiple-dose, 2-arm, Parallel-group Study to Evaluate Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 - Proposed Biosimilar to Denosumab with... not-yet-due